Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients

D. Lilleri, D. Andrea, A. Manuela, V. Rognoni, T. Oggionni, S. Miserere, M. Agnesi, F. Meloni (Pavia, Italy)

Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Session: Lung transplantation: pre- and postoperative problems
Session type: E-Communication Session
Number: 1423
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Lilleri, D. Andrea, A. Manuela, V. Rognoni, T. Oggionni, S. Miserere, M. Agnesi, F. Meloni (Pavia, Italy). Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients. Eur Respir J 2009; 34: Suppl. 53, 1423

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
CMV management in lung transplant recipients
Source: School Course 2012 - Lung Transplantation
Year: 2012


Pulmonary cytomegalovirus infections following renal transplantation
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012


Effective prevention of human cytomegalovirus (HCMV) disease in lung transplant recipients (LTR) by pre-emptive therapy based on HCMV monitoring in blood and lung
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019

Pulmonary viral infection in hematologic patients with and without stemcell transplantation
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011

Cytomegalovirus quantitative-PCR study in pulmonary tissue from lung transplant recipients
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010

Cytomegalovirus infection in lung transplant patients: the role of prophylaxis and recipient-donor serotype matching
Source: Eur Respir J 2005; 26: Suppl. 49, 636s
Year: 2005

Infectious complications after lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193
Year: 2003

Pulmonary cladophialophora boppii infection in a lung transplant recipient
Source: Eur Respir J 2006; 28: Suppl. 50, 777s
Year: 2006

Human lung transplantation: cytomegaloviral and rhinoviral co-infection is a distinct risk for acute rejection
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009

Prolonged oral ganciclovir (GCV) reduces the incidence of CMV infection and disease after lung transplantation (LTx)
Source: Eur Respir J 2006; 28: Suppl. 50, 777s
Year: 2006

Pneumococcal vaccination in interstitial lung disease patients receiving systemic immunosuppressive treatment
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017

Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Source: Eur Respir J 2016; 48: 1807-1810
Year: 2016


Incidence of viral infections in patients with lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012

Pulmonary complications in renal transplant recipients
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung
Source: Eur Respir J 2003; 21: 192-194
Year: 2003



The choice of mechanical ventilation in kidney transplant recipients with severe respiratory failure caused by pulmonary infection: invasive or noninvasive?
Source: Annual Congress 2008 - Use of noninvasive ventilation in various conditions
Year: 2008


Increased LIR-1 expression precedes serum cytomegalovirus detection and diagnosis of CMV disease in lung transplant recipients
Source: Eur Respir J 2002; 20: Suppl. 38, 347s
Year: 2002

Extrapulmonary tuberculosis in patients with chronic kidney disease receiving renal replacement therapy
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019


Pulmonary complications in heart transplant recipients
Source: Eur Respir J 2004; 24: Suppl. 48, 181s
Year: 2004

Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015